StockTipsArenaBeta

BUY Shilpa Medicare Limited — DAM Capital

BUYShilpa Medicare Limited

byDAM CapitalHorizon: 1 year30 Jun 2026via ET Now (Live)

Entry₹603Stated
Target₹748
Total upside +24.05% (call closed)
Stop lossNot given
Exit₹7485 Aug 2026, 12:08 pm
Target hit+24.05%0.00%upside left
Follow DAM Capital for new callsGet alertsWatch SHILPAMED for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 5 Aug 2026
3 supporting3 neutral1 opposing
Supports the BUY call (3)

Nothing found in this tip’s window yet.

Neutral / worth noting (3)

Shilpa Biologicals Private Limited, a material subsidiary of Shilpa Medicare Limited, has been assigned a credit rating of IND A+/Stable/IND A1+ for its bank loan facilities of INR 1,250 million by In

BSE · Company Update·16 Jul · 3w ago

(opens in new tab)

Shilpa Medicare Ltd has provided an intimation regarding its credit rating.

BSE · Company Update·7 Jul · 4w ago

(opens in new tab)
Weighs against the BUY call (1)

Dr. Sridevi Khambhampaty has resigned as Chief Executive Officer (CEO) of Shilpa Biologicals Private Limited, a material subsidiary of Shilpa Medicare Limited.

BSE · Company Update·15 Jul · 3w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.